---

Pharmacotherapy of gastrointestinal strongylosis of small ruminants: An update

Full Text PDF Share on Facebook Share on Twitter

---

Review Article

Author Details : Deto UJ-P N'guessan, Songuigama Coulibaly, Mahama Ouattara*

Volume : 8, Issue : 4, Year : 2021

Article Page : 159-166

https://doi.org/10.18231/j.ijpca.2021.031

Suggest article by email

Get Permission

Abstract

Gastrointestinal strongylosis, which causes deadly seasonal diarrhea in small ruminants, is a major threat to the livestock population in sub-Saharan Africa. Moreover, livestock is a central component of food security. In addition to this threat, there is a poor veterinary coverage due to the increasing lack of effective anthelmintic drugs against strongyles because of the emergence and proliferation of chemo resistant strains. In this context, and given that the use of a vaccine is not widespread, the establishment of the therapeutic arsenal available to veterinarians to control strongyles will contribute to the food and economic security of rural populations. This review outlines the main pharmacochemical classes of anthelmintics used in the management of strongylosis of small ruminants.

Keywords: Anthelmintics, Chemoresistant, Gastrointestinal, Strongylosis

How to cite : N'guessan D U, Coulibaly S, Ouattara M, Pharmacotherapy of gastrointestinal strongylosis of small ruminants: An update. Int J Pharm Chem Anal 2021;8(4):159-166

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.